Close

Marinus Pharma (MRNS) Announces Top-line Results from Phase 2 Study of Ganaxolone in PCDH19 Pediatric Epilepsy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. ENPH
3. TXN
4. SPOT
5. V
6. MSCI
7. STX
8. MAT
9. KMB
10. PII


Go back to Marinus Pharma (MRNS) Announces Top-line Results from Phase 2 Study of Ganaxolone in PCDH19 Pediatric Epilepsy